Published in J Clin Oncol on August 01, 1999
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. Int J Clin Oncol (2011) 5.39
Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer. Int J Clin Oncol (2015) 2.70
Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial. Lancet Oncol (2015) 1.67
Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy. Ann Surg (2002) 1.66
Optimal timing of surgery after chemoradiation for advanced rectal cancer: preliminary results of a multicenter, nonrandomized phase II prospective trial. Ann Surg (2011) 1.43
Preoperative radiochemotherapy and sphincter-saving resection for T3 carcinomas of the lower third of the rectum. Ann Surg (2001) 1.43
Efficacy and short-term outcomes of preoperative chemoradiotherapy with intermittent oral tegafur-uracil plus leucovorin in Japanese rectal cancer patients: a single center experience retrospective analysis. World J Surg Oncol (2017) 1.40
Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the total mesorectal excision trial. Ann Surg (2007) 1.20
Does the timing of esophagectomy after chemoradiation affect outcome? Ann Thorac Surg (2011) 1.19
Local excision after preoperative chemoradiation results in an equivalent outcome to total mesorectal excision in selected patients with T3 rectal cancer. Ann Surg Oncol (2009) 1.19
Reduced lymph node yield in rectal carcinoma specimen after neoadjuvant radiochemotherapy has no prognostic relevance. World J Surg (2009) 1.09
Sphincter saving rectum resection is the standard procedure for low rectal cancer. Int J Colorectal Dis (2003) 1.05
Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: correlation with endorectal ultrasound and histopathology. Eur J Nucl Med Mol Imaging (2004) 1.01
Current approaches and challenges for monitoring treatment response in colon and rectal cancer. J Cancer (2014) 1.00
Neoadjuvant-intensified treatment for rectal cancer: time to change? World J Gastroenterol (2013) 0.99
Patterns of local recurrence in rectal cancer after a multidisciplinary approach. World J Gastroenterol (2011) 0.96
Advances and challenges in treatment of locally advanced rectal cancer. J Clin Oncol (2015) 0.96
Interval between neoadjuvant treatment and definitive surgery in locally advanced rectal cancer: impact on response and oncologic outcomes. J Cancer Res Clin Oncol (2014) 0.94
Impact of neoadjuvant chemoradiation on pathologic response and survival of patients with locally advanced rectal cancer. Rep Pract Oncol Radiother (2010) 0.94
Extended Intervals after Neoadjuvant Therapy in Locally Advanced Rectal Cancer: The Key to Improved Tumor Response and Potential Organ Preservation. J Am Coll Surg (2015) 0.94
Chemoradiotherapy and adjuvant chemotherapy for rectal cancer. Int J Clin Oncol (2008) 0.94
SAGES evidence-based guidelines for the laparoscopic resection of curable colon and rectal cancer. Surg Endosc (2012) 0.93
Preoperative radiochemotherapy is successful also in patients with locally advanced rectal cancer who have intrinsically high apoptotic tumours. Ann Oncol (2008) 0.92
Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study. Radiat Oncol (2011) 0.92
Fourth versus eighth week surgery after neoadjuvant radiochemotherapy in T3-4/N0+ rectal cancer: Istanbul R-01 study. J Gastrointest Oncol (2014) 0.91
The use of preoperative radiotherapy in the management of patients with clinically resectable rectal cancer: a practice guideline. BMC Med (2003) 0.91
Interval to surgery after neoadjuvant treatment for colorectal cancer. World J Gastroenterol (2014) 0.90
Preoperative radiation therapy for locally advanced rectal cancer: a comparison between two different time intervals to surgery. Int J Colorectal Dis (2006) 0.90
A phase I/II study of oxaliplatin when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group (CCOG) study. Br J Cancer (2005) 0.89
Rectal cancer treatment: improving the picture. World J Gastroenterol (2007) 0.89
Long-term results of a randomized trial in locally advanced rectal cancer: no benefit from adding a brachytherapy boost. Int J Radiat Oncol Biol Phys (2014) 0.89
Phase II study of preoperative bevacizumab, capecitabine and radiotherapy for resectable locally-advanced rectal cancer. BMC Cancer (2015) 0.88
Oxaliplatin combined with infusional 5-fluorouracil and concomitant radiotherapy in inoperable and metastatic rectal cancer: a phase I trial. Br J Cancer (2005) 0.88
Lymph node retrieval in abdominoperineal surgical specimen is radiation time-dependent. World J Surg Oncol (2006) 0.88
Down-staging following neoadjuvant chemo-radiotherapy for locally advanced rectal cancer: Does timing of surgery really matter? Indian J Med Paediatr Oncol (2014) 0.87
Overview of radiation therapy for treating rectal cancer. Ann Coloproctol (2014) 0.86
Risk factors for local recurrence following neoadjuvant chemoradiotherapy for rectal cancers. World J Gastroenterol (2013) 0.86
Bromodeoxyuridine labeling index as an indicator of early tumor response to preoperative radiotherapy in patients with rectal cancer. J Gastrointest Surg (2007) 0.85
Preoperative oxaliplatin, capecitabine, and external beam radiotherapy in patients with newly diagnosed, primary operable, cT₃NxM0, low rectal cancer: a phase II study. Strahlenther Onkol (2011) 0.85
Optimal timing of surgery after neoadjuvant chemoradiation therapy in locally advanced rectal cancer. J Korean Surg Soc (2013) 0.83
The timing of surgery after preoperative short-course S-1 chemoradiotherapy with delayed surgery for T3 lower rectal cancer. Int J Colorectal Dis (2014) 0.82
Optimal Time Intervals between Pre-Operative Radiotherapy or Chemoradiotherapy and Surgery in Rectal Cancer? Front Oncol (2014) 0.82
Neoadjuvant treatment in rectal cancer: actual status. Chemother Res Pract (2011) 0.82
Intermediate neoadjuvant radiotherapy for T3 low/middle rectal cancer: postoperative outcomes of a non-controlled clinical trial. Oncotarget (2014) 0.81
Evaluation of Tumor Response after Short-Course Radiotherapy and Delayed Surgery for Rectal Cancer. PLoS One (2016) 0.81
Increased time from neoadjuvant chemoradiation to surgery is associated with higher pathologic complete response rates in esophageal cancer. Ann Thorac Surg (2014) 0.81
A Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer. Int J Biol Sci (2016) 0.80
Long-term efficacy of preoperative radiotherapy for locally advanced low rectal cancer. Int J Colorectal Dis (2007) 0.79
Advances in radiotherapy in operable rectal cancer. Dig Surg (2009) 0.79
Future directions in combined modality therapy for rectal cancer: reevaluating the role of total mesorectal excision after chemoradiotherapy. Onco Targets Ther (2013) 0.79
An observational study of extending FOLFOX chemotherapy, lengthening the interval between radiotherapy and surgery, and enhancing pathological complete response rates in rectal cancer patients following preoperative chemoradiotherapy. Therap Adv Gastroenterol (2016) 0.78
Usefulness of two independent histopathological classifications of tumor regression in patients with rectal cancer submitted to hyperfractionated pre-operative radiotherapy. World J Gastroenterol (2007) 0.78
Surgical issues in locally advanced rectal cancer treated by preoperative chemoradiotherapy. J Korean Surg Soc (2012) 0.78
Neoadjuvant oral vs. infusional chemoradiotherapy on locally advanced rectal cancer: Prognostic factors. Rep Pract Oncol Radiother (2012) 0.78
Sphincter preservation in distal CT2N0 rectal cancer after preoperative chemoradiotherapy. Radiat Oncol (2014) 0.77
The relationship of histological tumor regression grade (TRG) and two different time intervals to surgery following radiation therapy for locally advanced rectal cancer. Int J Colorectal Dis (2009) 0.77
Surgeon perspectives on the use and effects of neoadjuvant chemoradiation in the treatment of rectal cancer: a comprehensive review of the literature. Langenbecks Arch Surg (2015) 0.77
Clinical impact of tumor regression grade after preoperative chemoradiation for locally advanced rectal cancer: subset analyses in lymph node negative patients. J Korean Soc Coloproctol (2011) 0.77
Surgical timing after chemoradiotherapy for rectal cancer, analysis of technique (STARRCAT): results of a feasibility multi-centre randomized controlled trial. Tech Coloproctol (2016) 0.77
Comparison of treatment results between surgery alone, preoperative short-course radiotherapy, or long-course concurrent chemoradiotherapy in locally advanced rectal cancer. Int J Clin Oncol (2011) 0.76
Adjuvant therapy for rectal cancer. Clin Colon Rectal Surg (2007) 0.76
A Predictive Genetic Signature for Response to Fluoropyrimidine-Based Neoadjuvant Chemoradiation in Clinical Stage II and III Rectal Cancer. Front Oncol (2013) 0.76
Adjuvant and neoadjuvant chemoradiation or radiotherapy in rectal cancer--a review focusing on open questions. Int J Colorectal Dis (2007) 0.76
Treatment Interval between Neoadjuvant Chemoradiotherapy and Surgery in Rectal Cancer Patients: A Population-Based Study. Ann Surg Oncol (2016) 0.75
Results of intraoperative electron beam radiotherapy containing multimodality treatment for locally unresectable T4 rectal cancer: a pooled analysis of the Mayo Clinic Rochester and Catharina Hospital Eindhoven. J Gastrointest Oncol (2016) 0.75
Does Extending the Waiting Time of Low-Rectal Cancer Surgery after Neoadjuvant Chemoradiation Increase the Perioperative Complications? Gastroenterol Res Pract (2016) 0.75
Neoadjuvant Long-Course Chemoradiotherapy for Rectal Cancer: Does Time to Surgery Matter? Int Surg (2015) 0.75
Early vs. Late Chemoradiation Therapy and the Postoperative Interval to Adjuvant Therapy Do Not Correspond to Local Recurrence in Resected Pancreatic Cancer. Pancreat Disord Ther (2015) 0.75
Neoadjuvant chemoradiotherapy of the rectal carcinoma - The correlation between the findings on the restaging multiparametric 3T MRI scanning and the surgical findings. Rep Pract Oncol Radiother (2017) 0.75
Timing of surgery following chemoradiotherapy in rectal Cancer. Indian J Med Paediatr Oncol (2014) 0.75
17-Week Delay Surgery after Chemoradiation in Rectal Cancer with Complete Pathological Response. Case Rep Surg (2015) 0.75
Principles of radiation oncology: a beams eye view for a surgeon. Indian J Surg Oncol (2013) 0.75
Pre- and post-surgery treatments in rectal cancer: a long-term single-centre experience. Curr Oncol (2017) 0.75
Delaying surgery after neoadjuvant chemoradiotherapy improves prognosis of rectal cancer. World J Gastrointest Oncol (2016) 0.75
Less than 12 lymph nodes in the surgical specimen after neoadjuvant chemo-radiotherapy: an indicator of tumor regression in locally advanced rectal cancer? J Gastrointest Oncol (2016) 0.75
Neoadjuvant radiochemotherapy in the treatment of fixed and semi-fixed rectal tumors. Analysis of results and prognostic factors. Radiat Oncol (2006) 0.75
Genomic predictor of complete response after chemoradiotherapy in rectal cancer. Ann Transl Med (2016) 0.75
Comparison of neoadjuvant oral chemotherapy with UFT plus Folinic acid or Capecitabine concomitant with radiotherapy on locally advanced rectal cancer. Rep Pract Oncol Radiother (2012) 0.75
The best timing for administering systemic chemotherapy in patients with locally advanced rectal cancer. Ann Transl Med (2016) 0.75
Effect of Interval between Neoadjuvant Chemoradiotherapy and Surgery on Oncological Outcome for Rectal Cancer: A Systematic Review and Meta-Analysis. Gastroenterol Res Pract (2016) 0.75
Preoperative bi-fractionated accelerated radiation therapy for combined treatment of locally advanced rectal cancer in a consectutive series of unselected patients. Int Semin Surg Oncol (2007) 0.75
Preoperative short- vs. long-course chemoradiotherapy with delayed surgery for locally advanced rectal cancer. Oncotarget (2016) 0.75
Predicting the pathologic response of locally advanced rectal cancer to neoadjuvant concurrent chemoradiation using enzyme-linked immunosorbent assays (ELISAs) for biomarkers. J Cancer Res Clin Oncol (2014) 0.75
A minimum yield of twelve lymph nodes in rectal cancer remains valid in the era of neo-adjuvant treatment : results from a national cohort study. Int J Colorectal Dis (2015) 0.75
Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer (2000) 4.70
Relapses and progression of disability in multiple sclerosis. N Engl J Med (2000) 4.17
Cystadenomas and cystadenocarcinomas of the pancreas: a multiinstitutional retrospective study of 398 cases. French Surgical Association. Ann Surg (1999) 3.09
Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects. J Immunol (1984) 3.07
Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol (2003) 2.87
Improvement of cerebellar ataxia with levorotatory form of 5-hydroxytryptophan. A double-blind study with quantified data processing. Arch Neurol (1988) 2.23
Diagnostic value of endoscopic capsule in patients with obscure digestive bleeding: blinded comparison with video push-enteroscopy. Endoscopy (2003) 2.20
Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: a phase II study. J Clin Oncol (2003) 2.07
Endocavitary irradiation for early rectal carcinomas T1 (T2). A series of 101 patients treated with the Papillon's technique. Int J Radiat Oncol Biol Phys (1996) 1.99
Laparoscopic treatment of perforated peptic ulcer. Br J Surg (1990) 1.98
Long-term survival after photodynamic therapy for esophageal cancer. Gastroenterology (1995) 1.96
[Dysplasia of the femoral trochlea]. Rev Chir Orthop Reparatrice Appar Mot (1990) 1.86
Old microbleeds are a potential risk factor for cerebral bleeding after ischemic stroke: a gradient-echo T2*-weighted brain MRI study. Stroke (2002) 1.82
Intraductal papillary and mucinous tumors of the pancreas: accuracy of preoperative computed tomography, endoscopic retrograde pancreatography and endoscopic ultrasonography, and long-term outcome in a large surgical series. Gastrointest Endosc (1998) 1.78
Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation. Hepatology (1997) 1.74
Adjuvant gemcitabine and concurrent radiation for patients with resected pancreatic cancer: a phase II study. Br J Cancer (2006) 1.71
Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer. Arch Surg (2004) 1.59
Miniprobe EUS in the pretherapeutic assessment of early esophageal neoplasia. Endoscopy (2007) 1.58
Contrast-enhanced harmonic endoscopic ultrasound in solid lesions of the pancreas: results of a pilot study. Endoscopy (2010) 1.57
Preoperative vitreous hemorrhage associated with rhegmatogenous retinal detachment: a risk factor for postoperative proliferative vitreoretinopathy? Graefes Arch Clin Exp Ophthalmol (1996) 1.56
Failure of traditional trough levels to predict tacrolimus concentrations. Ther Drug Monit (2001) 1.50
Better efficacy of methotrexate given by intramuscular injection than orally in patients with rheumatoid arthritis. Ann Rheum Dis (2004) 1.44
Should we inhibit gastric acid secretion before cardiac surgery? Anesth Analg (1990) 1.42
[Delayed colo-anal anastomosis after laparoscopic proctectomy with total mesorectal resection for rectal cancer]. J Chir (Paris) (2008) 1.39
The role of radiotherapy in the conservative treatment of rectal carcinoma--the Lyon experience. Acta Oncol (1998) 1.39
Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801). Ann Oncol (2005) 1.39
Predictors of long-term survival after liver transplantation for metastatic endocrine tumors: an 85-case French multicentric report. Am J Transplant (2008) 1.38
Response of experimental animals to human carcinogens: an analysis based upon the IARC Monographs programme. Carcinogenesis (1986) 1.35
Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer. Fondation Française de Cancérologie Digestive. Br J Surg (1995) 1.34
[IMesenteric and mesocolic cystic lymphangiomas. Diagnostic and therapeutic management]. Ann Chir (2002) 1.34
Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin. Br J Surg (2004) 1.30
Altered homologous and heterologous gap-junctional intercellular communication in primary human liver tumors associated with aberrant protein localization but not gene mutation of connexin 32. Int J Cancer (1994) 1.29
Vitamin D supplementation during pregnancy: effect on neonatal calcium homeostasis. J Pediatr (1986) 1.29
Interstitial curietherapy in the conservative treatment of anal and rectal cancers. Int J Radiat Oncol Biol Phys (1989) 1.29
Endoscopic mucosal resection for squamous premalignant and early malignant lesions of the esophagus. Endoscopy (2007) 1.28
An IARC evaluation of polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans as risk factors in human carcinogenesis. Environ Health Perspect (1998) 1.27
Quantification of MRI lesion load in multiple sclerosis: a comparison of three computer-assisted techniques. Magn Reson Imaging (1996) 1.25
A comparative study of medial versus lateral arthroscopic partial meniscectomy on stable knees: 10-year minimum follow-up. Arthroscopy (2003) 1.21
Pancreaticoduodenectomy for metastatic ampullary and pancreatic tumors. Hepatogastroenterology (2000) 1.21
Diagnosis and treatment of biliary obstruction caused by portal cavernoma. Endoscopy (2003) 1.20
Somatostatin in mucosa of stomach and duodenum in gastroduodenal disease. Gastroenterology (1978) 1.19
What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: surrogacy in question? Eur J Cancer (2012) 1.17
Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis. Cancer (2000) 1.17
Randomized controlled multicentre trial of somatostatin infusion after pancreaticoduodenectomy. Br J Surg (2001) 1.16
Intraocular foreign bodies. Factors influencing final visual outcome. Acta Ophthalmol Scand (1999) 1.15
Amplification of epidermal growth factor receptor gene but no evidence of ras mutations in primary human esophageal cancers. Cancer Res (1988) 1.14
Conservative treatment of low rectovaginal fistula in Crohn's disease. Int J Colorectal Dis (1990) 1.14
Early detection of cerebral arterial occlusion on magnetic resonance angiography: predictive value of the baseline NIHSS score and impact on neurological outcome. Cerebrovasc Dis (2002) 1.10
Prevention of lymphorrhea by means of fibrin glue after axillary lymphadenectomy in breast cancer: prospective randomized trial. Eur Surg Res (1998) 1.10
Long-term results of the Lyons R90-01 randomized trial of preoperative radiotherapy with delayed surgery and its effect on sphincter-saving surgery in rectal cancer. Br J Surg (2003) 1.09
The predictive value of mouse liver tumour induction in carcinogenicity testing--a literature survey. Int J Cancer (1973) 1.08
Thrombolysis with intravenous rtPA in a series of 100 cases of acute carotid territory stroke: determination of etiological, topographic, and radiological outcome factors. Stroke (1998) 1.08
Management of postoperative chylothorax. J Visc Surg (2011) 1.05
Hyperbaric oxygen in the treatment of acute ischemic stroke. A double-blind pilot study. Stroke (1995) 1.04
Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study. Neurology (1996) 1.03
Adjuvant intraperitoneal 5-fluorouracil in high-risk colon cancer: A multicenter phase III trial. Ann Surg (2000) 1.02
Clinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activator. J Neurol Neurosurg Psychiatry (2005) 1.01
Baseline magnetic resonance imaging parameters and stroke outcome in patients treated by intravenous tissue plasminogen activator. Stroke (2003) 1.01
Results of radiation therapy in carcinoma of the proximal bile duct (Klatskin tumor). Semin Liver Dis (1990) 1.01
Cerebral venous thrombosis: clinical outcome and systematic screening of prothrombotic factors. Neurology (2003) 1.01
Activation of a distributed somatosensory cortical network in the human brain. A dipole modelling study of magnetic fields evoked by median nerve stimulation. Part I: Location and activation timing of SEF sources. Electroencephalogr Clin Neurophysiol (1997) 1.00
The natural history of the knee following arthroscopic medial meniscectomy. Knee Surg Sports Traumatol Arthrosc (2001) 1.00
A randomised evaluation of two techniques of management of the third stage of labour in women at low risk of postpartum haemorrhage. BJOG (2000) 0.99
Multidisciplinary treatment of cerebral arteriovenous malformations. Neurol Res (1995) 0.98
Hepatic outflow study after piggyback liver transplantation. Surgery (1996) 0.98
Complications after multidisciplinary treatment of cerebral arteriovenous malformations. Acta Neurochir (Wien) (1996) 0.97
Mechanical characteristics of fresh and frozen human descending thoracic aorta. J Surg Res (1996) 0.97
[Effect of age on the natural history of the shoulder: a clinical and radiological study in the elderly]. Rev Chir Orthop Reparatrice Appar Mot (2005) 0.97
[Excision of carcinomas of the rectal ampulla via the inferior route. The parachute technic]. Nouv Presse Med (1974) 0.94
Evaluation of the carcinogenic risks to humans associated with surgical implants and other foreign bodies - a report of an IARC Monographs Programme Meeting. International Agency for Research on Cancer. Eur J Cancer (2000) 0.94
Temporopolar changes in temporal lobe epilepsy: a quantitative MRI-based study. Neurology (2002) 0.94
Peripheral cholangiocarcinoma: presentation, diagnosis, pathology and management. Eur J Surg Oncol (1999) 0.93
Peritonectomy combined with intraperitoneal chemohyperthermia in abdominal cancer with peritoneal carcinomatosis: phase I-II study. Anticancer Res (1999) 0.92
[Results of surgically treated chronic anterior laxities. Apropos of 251 cases reviewed with a minimum follow-up of 3 years]. Rev Chir Orthop Reparatrice Appar Mot (1988) 0.91
Outcome of ileal pouch after secondary diagnosis of Crohn's disease. Int J Colorectal Dis (2000) 0.91
Dysmyelopoietic syndromes. A search for prognostic factors in 193 patients. Cancer (1983) 0.91
Curative non-surgical combined treatment of squamous cell carcinoma of the oesophagus. Eur J Cancer (1992) 0.91
Preaortic paraganglioma mimicking a hypervascular tumor of the pancreas. Hepatogastroenterology (2004) 0.91
Visual outcome and prognostic factors after magnetic extraction of posterior segment foreign bodies in 40 cases. Br J Ophthalmol (1998) 0.91
Activation of a distributed somatosensory cortical network in the human brain: a dipole modelling study of magnetic fields evoked by median nerve stimulation. Part II: Effects of stimulus rate, attention and stimulus detection. Electroencephalogr Clin Neurophysiol (1997) 0.90
[C-reactive protein usefulness in diagnosis and survey of Crohn's disease and ulcerative colitis (author's transl)]. Gastroenterol Clin Biol (1979) 0.90
A new approach to the management of epidermoid carcinoma of the anal canal. Cancer (1983) 0.90
Liver transplantation for multiple angiomyolipomas complicating tuberous sclerosis complex. Gastroenterol Clin Biol (2010) 0.90
Transjugular intra-hepatic portosystemic shunt for refractory variceal bleeding. Eur J Gastroenterol Hepatol (2001) 0.89
Endoscopic ultrasonography of a pancreatic lymphoma. Endoscopy (1998) 0.89
Combined chemotherapy and radiotherapy followed by surgery in the treatment of patients with squamous cell carcinoma of the esophagus. Cancer (2000) 0.89
Clinical and hormonal effects of a long-acting somatostatin analogue in pancreatic endocrine tumors and in carcinoid syndrome. Cancer (1987) 0.89
Unresectable hepatocellular carcinoma: survival and prognostic factors after lipiodol chemoembolisation in 89 patients. Dig Liver Dis (2006) 0.88
Stereotactic radiosurgery: the Lyon experience. Acta Neurochir Suppl (1995) 0.88